DRUG DEVELOPMENT

Advertisement
Jan 28 2026HEALTH

Asthma Breakthrough: New Molecules Could Change the Game

Asthma is a tricky condition. For a long time, scientists thought they knew what caused the inflammation in the lungs. They blamed leukotrienes, chemicals made by white blood cells. But now, a new discovery might change everything. Researchers found something unexpected. There are other molecules,

reading time less than a minute
Jan 22 2026HEALTH

Harmless Cancers: The Hidden Clues for New Treatments

Cancer is often seen as a relentless foe. But what if some cancers are not so aggressive? What if they can be controlled by the body's own defenses? This idea is not just a theory. It is being explored in a new way. Scientists have noticed that some cancers do not grow or spread. They stay in the b

reading time less than a minute
Jan 22 2026HEALTH

A New Hope in the Fight Against Colon Cancer

Scientists have created new molecules to fight colorectal cancer. These molecules target a specific pathway in cells that is often overactive in cancer. The most promising molecule, called L20, stops cancer cells from growing and spreading. L20 works by sticking to a protein called STAT3. This prot

reading time less than a minute
Jan 10 2026HEALTH

A New Hope in the Fight Against Gallbladder Cancer

Gallbladder cancer is a serious disease. It is the most common cancer of the bile ducts. Finding new treatments is very important. Researchers have found something promising. It is called total glucosides of paeony, or TGP. This comes from a traditional Chinese herb called Bai Shao. TGP does two im

reading time less than a minute
Jan 09 2026SCIENCE

Unlocking the Secrets of SHP2: A Key Player in Disease and Drug Development

SHP2, a protein known for its role in various diseases like cancer and RASopathies, is a hot topic in medical research. It's often mutated in these conditions, making it a prime target for new drug development. SHP2 is part of a complex system that helps cells grow and communicate, and it's tightly

reading time less than a minute
Jan 07 2026BUSINESS

Big Pharma's Urgent Quest for New Drugs

Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi

reading time less than a minute
Dec 16 2025HEALTH

A New Hope for Tough-to-Treat Leukemia

In the world of medical research, a new player has emerged that could change the game for people with a tough type of blood cancer called acute myeloid leukemia (AML). This cancer is notorious for being resistant to many treatments, especially in cases with complex genetic issues like MECOM rearrang

reading time less than a minute
Nov 30 2025HEALTH

A Hidden Threat: The Quest to Tame Lipoprotein(a)

Lipoprotein(a), or Lp(a) for short, is a sneaky little molecule lurking in your bloodstream. Unlike cholesterol, it's not something you can easily control with diet or exercise. It's a genetic gift that can lead to serious health issues, like heart disease and aortic stenosis. Most folks are famili

reading time less than a minute
Nov 25 2025HEALTH

Semaglutide Pill Falls Short in Alzheimer's Battle

A recent study has brought disappointing news for those hoping to combat Alzheimer's disease. The drug semaglutide, known for its effectiveness in managing diabetes and obesity, did not show any significant benefits in slowing down the progression of Alzheimer's. This was revealed in two large-scale

reading time less than a minute
Nov 25 2025BUSINESS

Big Pharma Hits a Trillion-Dollar Jackpot

Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.

reading time less than a minute